New combo targets gut bacteria to fight advanced colon cancer
Disease control
Ongoing
This study tests a combination of three drugs (Tislelizumab, Fruquintinib, and Metronidazole) in 33 adults with advanced colorectal cancer that has a high level of a specific gut bacteria called Fusobacterium nucleatum. The goal is to see if this treatment can slow or stop cancer…
Phase: PHASE2 • Sponsor: Jing-yuan Fang, MD, Ph. D • Aim: Disease control
Last updated May 09, 2026 07:19 UTC